Bullish Tuesday For Marijuana Stocks – Sundial, Aurora, Tilray & Cronos Among Top Gainers
GAINERS:
Rhinomed (OTC:RHNMF) shares closed up 25.36% at $0.26 with an estimated market cap of $66,497,992.
New Jersey’s Recreational Cannabis Program May Be ‘A Wreck’ But A Few Companies Could Emerge As Winners
In the most recent November elections, fully 67% of New Jersey's adult voters came out to say yes to legalize cannabis.
Should You Buy Trulieve Stock Before Its $2.1B Merger?
Over the last three months, Trulieve (OTCQX: TCNNF) shares lost 32%, compared to a 19% drop in AdvisorShares Trust AdvisorShares Pure US Cannabis ETF (ARCA: MSO
MSOs Cannabis ETF Manager Weighs In On Green Thumb Industries, Trulieve & Cresco Labs Post Earnings
After an earnings-heavy week, where many of the largest cannabis companies reported their quarterly results, Benzinga caught up with Dan Ahrens, portfolio manager of the AdvisorShares Pure US Cannabis ETF (NYSE: MSOS) and the AdvisorShares Pure Cannabis ETF (
Cannabis Industry Chart Of The Week: Q2 Earnings Releases Have Failed To Rally Marijuana Stocks
Last week seven of the eleven MSOs with more than $1B market caps reported Q2 results. The chart shows the percentage difference between actual Revenue and EBITDA versus consensus analyst estimates, and the percent change of the stocks post announcement.
Bearish Wave Dumps Marijuana Stocks – GrowGeneration Sundial Growers And Aurora Cannabis Among Top Cannabis Movers For Today – Tilray Down By 6%
GAINERS:
Cipher Pharms Inc (OTC:CPHRF) shares closed up 20.19% at $1.62 with an estimated market cap of $43,398,257.
The Week In Cannabis: An Earnings Avalanche, Biden’s Clemency Plans, Cuomo’s Resignation And More
Below is a recap of the main news related to the cannabis industry and markets for the week of August 13, 2021, which was marked by earnings reports out of many of the largest companies in the space – all details below.
Cantor Is Bullish On Trulieve’s Q2 Financials, But Remains Cautious Of Possible Risks Ahead, Drops Price Target To $50
Following financial results showing 14 consecutive quarters of profitability released by Trulieve Cannabis Corp.
Green Thumb Industries Price Target Raised By Cantor As It Reports Q2 Results, 85.4% YoY Spike In Revenue
Cannabis company Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF), the owner of Rise Dispensaries, revealed on Wednesday after the market close that its revenue spiked 85.4% year-over-year and 14.1% sequentially - 7% above FactSet consensus - reaching $221.9 million in the qua
Cantor Fitzgerald Maintains Overweight on Green Thumb Industries, Raises Price Target to $46
Cantor Fitzgerald analyst Pablo Zuanic maintains Green Thumb Industries (OTC:GTBIF) with a Overweight and raises the price target from $43.5 to $46.